NCT05501002 - Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

September 15, 2023

Study Completion Date

September 15, 2023

Conditions

HydrocephalusHydrocephalus, Communicating

Interventions

DEVICE

eShunt® Implant

The eShunt® Implant is intended to drain excess cerebrospinal fluid from the intracranial subarachnoid space to the venous system as a less invasive therapy for treating hydrocephalus.

Trial Locations (2)

10467

Montefiore Medical Center Department of Neurosurgery, New York

06511

Yale University, New Haven